Viewing Study NCT06649292


Ignite Creation Date: 2025-12-24 @ 3:31 PM
Ignite Modification Date: 2026-01-19 @ 10:30 PM
Study NCT ID: NCT06649292
Status: RECRUITING
Last Update Posted: 2024-12-12
First Post: 2024-10-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: SHR-A1904 Compared With Investigator's Choice of Therapy in Claudin18.2 Positive Patitens With Second-line Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Sponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module